1.Application of percutaneous transesophageal gastro-tubing in palliative treatment of malignant bowel obstruction
Hideki Aragane ; Masanori Shimomura ; Satoshi Inada ; Tomoko Katano ; Hitoshi Yasui ; Keitaro Kan ; Masahiro Shimizu
Palliative Care Research 2008;3(2):335-342
Percutaneous transesophageal gastro-tubing (PTEG) is considered a safe and effective treatment technique for drainage or feeding in patients with malignant bowel obstruction. We report six cases with malignant bowel obstruction due to recurrent gastric cancer whose bowel symptoms were satisfactory improved with PTEG. Ileus tubes were inserted in three of the six patients for decompression of the alimentary tract, a feeding tube was inserted in one patient for enteral feeding, and double elementary diet tubes (W-ED tube) were inserted in other two for decompression and enteral feeding. The median indwelling duration was 52days (rang; 24-460days). Home enteral nutrition was possible for the three patients with feeding tube and W-ED tube. Regarding decompression of alimentary tract, PTEG relieved the symptoms of all patients. One patient suffered from dermatitis around the inserted part of ileus tube because of the leakage of gastro-intestinal juice, and the ileus tube was removed. In two cases, the inserted tubes were exchanged because of the tube obstruction. PTEG made possible to use various types of tube depending on the state of the disease. From our experience, it is suggested that PTEG technique is an effective and useful procedure of choice for long-term drainage or feeding in patients with malignant bowel obstruction. Palliat Care Res 2008; 3(2): 335-342
2.A Report on an Annual Kampo Medicine Conference Held by Medical Students in the Hokkaido and Tohoku Areas
Shohei OKADA ; Fumiya OMATA ; Takafumi TOGASHI ; Takahisa OKUDA ; Tesshin MIYAMOTO ; Miho OOSUGA ; Kohei TANAKA ; Mami ISHIYAMA ; Aiseio AISO ; Hiromichi YASUI ; Minoru YAEGASHI ; Kahori KUBO ; Soichiro KANEKO ; Tetsuharu KAMIYA ; Natsumi SAITO ; Ryutaro ARITA ; Hidekazu WATANABE ; Hitoshi NISHIKAWA ; Yuka IKENO ; Junichi TANAKA ; Minoru OHSAWA ; Akiko KIKUCHI ; Takehiro NUMATA ; Hitoshi KURODA ; Michiaki ABE ; Shin TAKAYAMA ; Tadashi ISHII
Kampo Medicine 2017;68(1):72-78
Since students who would like to study Kampo medicine more have no opportunity to communicate each other in Northern Japanese Universities, we newly started joint study conferences held by medical students in 2013. The objectives of this paper are to report on these annually held student-based Kampo study conferences in the Hokkaido and Tohoku areas, and the ways each university studies Kampo medicine. In the conference, the students reported on their club activities. Then they studied the history of Kampo medicine and simulation of abdominal diagnosis, and performed group work on case reports together. The number of student participants in these conferences has tripled over 3 years from 18 to 58 (for a total of 111 participants). All members were satisfied with the content. And this reflects medical students' need for a wider perception of Kampo medicine, rather than a limited one gained in their university club activities. We hope this conference will play a major role in other nationwide student-based Kampo study conferences in the years to come.
3.Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder
Norio YASUI-FURUKORI ; Naoto ADACHI ; Yukihisa KUBOTA ; Takaharu AZEKAWA ; Eiichiro GOTO ; Koji EDAGAWA ; Eiichi KATSUMOTO ; Seiji HONGO ; Hitoshi UEDA ; Kazuhira MIKI ; Masaki KATO ; Reiji YOSHIMURA ; Atsuo NAKAGAWA ; Toshiaki KIKUCHI ; Takashi TSUBOI ; Koichiro WATANABE ; Kazutaka SHIMODA
Clinical Psychopharmacology and Neuroscience 2020;18(4):599-606
Objective:
Several evidence-based practice guidelines have been developed to better treat bipolar disorder. However, the articles cited in these guidelines were based on clinical or basic studies with specific conditional settings and were not sufficiently based on real-world clinical practice. In particular, there was little information on the doses of mood stabilizers.
Methods:
The MUlticenter treatment SUrvey on BIpolar disorder in Japanese psychiatric clinics (MUSUBI) is a study conducted to accumulate evidence on the real-world practical treatment of bipolar disorder. The questionnaire included patient characteristics such as comorbidities, mental status, treatment period, Global Assessment of Functioning (GAF) score, and details of pharmacological treatment.
Results:
Most patients received mood stabilizers such as lithium (n = 1,317), valproic acid (n = 808), carbamazepine (n = 136), and lamotrigine (n = 665). The dose of lithium was correlated with age, body weight, number of episodes, depression and GAF. The dose of valproic acid was correlated with body weight, number of episodes, presence of a rapid cycle and GAF. The dose of carbamazepine was correlated with age, mania, and the presence of a rapid cycle. The dose of lamotrigine was correlated with the number of episodes, depression, mania, psychotic features, and the presence of a rapid cycle. Doses of coadministered mood stabilizers were significantly correlated, except for the combination of valproic acid and lamotrigine.
Conclusion
The dose of mood stabilizers was selectively administered based on several factors, such as age, body composition, current mood status and functioning. Further prospective studies are required to confirm these findings.
4.The Current Situation and Problems of Domestic Crude Drug Production
Denichiro YAMAOKA ; Takashi ITO ; Hiroshi ASAMA ; Yoshiro SAHASHI ; Kazuo MITANI ; Donghyo KANG ; Hiromichi YASUI ; Hitoshi WATANABE
Kampo Medicine 2017;68(3):270-280
The consumption and sales of Kampo products, as well as the crude drugs that make up the products, have been increasing recently. However, the Kampo industry has been exhibiting a long-term decline due to the rise in price of imported crude drugs and reduction in standard prices of crude drugs by the Japanese National Health Insurance scheme. As the production of crude drug in Japan has been decreasing for the past thirty years, efforts have been made to improve the situation. Although the production of Aizu Ginseng decreased from 153 metric tons to 8 metric tons in Fukushima, university research institutes have initiated research on expansion of the farm field for Ginseng and reduction in a cultivation term. In Nara, farmers, pharmaceutical and food manufacturers, and university research institutes, aiming to develop new products using Yamato Angelica root, organized a joint council and have been working together to establish integrated systems from cultivation to sales. The Ministry of Agriculture, Forestry and Fisheries, the Ministry of Health, Labour and Welfare, and Japan Kampo Medicines Manufacturers Association have held local meetings with farmers and pharmaceutical companies in different areas throughout Japan over the past three years from fiscal year 2013. In order to reduce national healthcare costs by Kampo medicine, it is necessary to upgrade the health care system where not only Kampo extract products but also medicinal plants as raw materials including decoctions can be used. Discussions on measures to cover the costs of domestic production of crude drugs should be required.